ArticleLasers in medical science2025
Intraocular pressure-lowering effects of selective laser trabeculoplasty for normal tension glaucoma patients in Chinese.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
To evaluate the efficacy of selective laser trabeculoplasty (SLT) on intraocular pressure (IOP) for the normal tension glaucoma (NTG) in Chinese. Consecutive patients with NTG treated with monocular SLT for eye with higher IOP were enrolled. IOP was evaluated for each patient before SLT, 1 h, 1 week, 1, 3, 6 months, 1 and 2 years after treatment. The treatment success was defined as IOP reduction from the preoperative IOP by 20%. Thirty-two patients with 18.47 ± 9.98 months follow-up were eligible for analyses. The mean IOP reduction after SLT were 2.80 mmHg (15.76%), 2.60 mmHg (15.57%), 2.51 mmHg (15.06%), 3.42 mmHg (20.51%), and 2.41 mmHg (14.46%) at 1, 3, 6 months, 1 and 2 years post-SLT respectively for the treated eyes. While there were 1.39 mmHg (8.94%) and 2.13 mmHg (13.71%) IOP reduction in the fellow eyes at 1 month and 1 year post-SLT respectively. There was positive correlation of IOP reduction between SLT eyes and the fellow eyes (r = 0.6503, P < 0.0001). The absolute success rate for SLT treated eyes mounted to 41.38% at 6 months and decreased to 18.18% at 2 years post-SLT. The success was associated with the number of medicines, pre-IOP and the IOP reduction at 1 and 3 months after SLT. SLT has an effect on lowering IOP for NTG patients in Chinese in both SLT eyes and the follow eyes with insufficient efficacy of anti-glaucoma medications, although the effect was not sustained with a longer follow-up.
Indexed as
Identifiers
40186709What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.